Shandong Weigao Group Medical Polymer (OTCMKTS:SHWGF) Upgraded to “Buy” at The Goldman Sachs Group

The Goldman Sachs Group upgraded shares of Shandong Weigao Group Medical Polymer (OTCMKTS:SHWGF – Get Rating) from a neutral rating to a buy rating in a research report sent to investors on Monday morning, The Fly reports.

Shandong Weigao Group Medical Polymer Stock Performance

OTCMKTS SHWGF opened at $1.73 on Monday. Shandong Weigao Group Medical Polymer has a 12 month low of $1.06 and a 12 month high of $1.73. The company’s 50-day moving average price is $1.71 and its 200-day moving average price is $1.62.

Shandong Weigao Group Medical Polymer Company Profile

(Get Rating)

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments.